The biochemical and functional food properties of the Bowman-Birk inhibitor

Critical Reviews in Food Science and Nutrition

Volumn 48, Issue 1, 2008, Pages 94-118

  Losso, Jack N ^a  

^a LOUISIANA STATE UNIVERSITY AGRICULTURAL CENTER   (United States)

Author keywords

Angiogenesis; Bowman Birk inhibitor; Cancer; Functional foods; Soybean (Glycine max); Tryptase and or chymase inhibitor

Indexed keywords

BOWMAN BIRK INHIBITOR; PEPTIDE HYDROLASE;

AMINO ACID SEQUENCE; ANIMAL; ARTICLE; BINDING SITE; BIOAVAILABILITY; CHEMICAL STRUCTURE; CHEMISTRY; CHEMOPROPHYLAXIS; CLASSIFICATION; DIET; DRUG STABILITY; HEALTH PROMOTION; HUMAN; METABOLISM; MOLECULAR GENETICS; PLANT; PLANT SEED; SOYBEAN;

AMINO ACID SEQUENCE; ANIMALS; BINDING SITES; BIOLOGICAL AVAILABILITY; CHEMOPREVENTION; DIET; DRUG STABILITY; HEALTH PROMOTION; HUMANS; MOLECULAR SEQUENCE DATA; MOLECULAR STRUCTURE; PEPTIDE HYDROLASES; PLANTS; SEEDS; SOYBEANS; TRYPSIN INHIBITOR, BOWMAN-BIRK SOYBEAN;

ANIMALIA; GLYCINE MAX;

EID: 39349086395     PISSN: 10408398     EISSN: 15497852     Source Type: Journal    
DOI: 10.1080/10408390601177589     Document Type: Article

References (247)

1. Adair, J. C., Charlie, J., Dencoff, J. E., Kaye, J. A., Quinn, J. F., Camicioli, R. M., Stetler-Stevenson, W. G., and Rosenberg, G. A. 2004. Measurement of gelatinase B (MMP-9) in the cerebrospinal fluid of patients with vascular dementia and Alzheimer disease. Stroke, 35:159-162.
2. Ala-Aho, R., and Kahari, V. M. 2005. Collagenases in cancer. Biochimie, 87:273-286.
3. Anderson, J. W., Blake, J. E., Turner, J., and Smith, B. M. 1998. Effects of soy protein on renal function and proteinuria in patients with type 2 diabetes. Am. J. Clin. Nutr. 68:1347S-1353S.
4. Anderson, J. W., Blake, J. E., Turner, J., and Smith, B. M. 1998. Effects of soy protein on renal function and proteinuria in patients with type 2 diabetes. Am. J. Clin. Nutr., 68(Suppl.):1347S-1353S.
5. Annapuma, S. S., Ramadoss, C. S., and Prasad, D. S. 1991. Characterization of a trypsin/chymotrypsin inhibitor from Jack fruit. J. Sci. Food Agric., 54:605-618.
6. Arentoft, A. M., Frokiaer H., Michaelsen, S., Sorensen, H., and Sorensen, S. J. 1993. High performance capillary electrophoresis for the determination of trypsin and chymotrypsin inhibitors and their association with trypsin, chymotrypsin and monoclonal antibodies. J. Chromatogr., 652:189-198.
7. Armstrong, W. B., Kennedy, A. R., Wan, S. X., Taylor, T. H., Nguyen, Q. A., Jensen, J., Thompson, W., Lagerberg, W., and Meyskens, F. L. Jr. 2000b. Clinical modulation of oral leukoplakia and protease activity by Bowman-Birk inhibitor concentrate in a phase IIa chemoprevention trial. Clin. Cancer Res., 6:4684-4691.
8. Armstrong, W. B., Kennedy, A. R., Wan, X. S., Atiba, J., McClaren, C. E., and Meyskens, Fl., Jr. 2000a. Single-dose administration of Bowman-Birk inhibitor concentrate in patients with oral leukoplakia. Cancer Epidemiol. Biomark. Prev., 9:43-47.
9. Armstrong, W. B., Wan, S. X., Kennedy, A. R., Taylor, T. H., and Meyskens, F. L. Jr. 2003. Development of the Bowman-Birk inhibitor for oral cancer chemoprevention and analysis of Neu immunohistochemical staining intensity with Bowman-Birk inhibitor concentrate treatment. Laryngoscope, 113:1687-1702.
10. Ary, M. B., Shewry, P. R., and Richardson, M. (1988).The amino acid sequence of a cereal Bowman-Birk type trypsin inhibitor from seeds of Job's tears (Coix lachryma-jobi L.). FEBS Lett., 229:111-118.
11. Azzouz, H., Cherqui, A., Campan, E. D., Rahbe, Y., Duport, G., Jouanin, L., Kaiser, L., and Giordanengo, P. 2005. Effects of plant protease inhibitors, oryzacystatin I and soybean Bowman-Birk inhibitor, on the aphid Macrosiphum euphorbiae (Homoptera, Aphididae) and its parasitoid Aphelinus abdominalis (Hymenoptera, Aphelinidae). J. Insect Physiol., 51:75-86.
12. Baek, J. M., Song, J. C., Choi, Y. D., and Kim, S. I. 1994. Nucleotide sequence homology of cDNAs encoding soybean Bowman-Birk type proteinase inhibitor and its isoinhibitors. Biosci. Biotechnol. Biochem. 58:843-846.
13. Baker, E. A., Bergin, F. G., and Leaper, D. J. 2000. Matrix metalloproteinases, their tissue inhibitors and colorectal cancer staging. Br. J. Surg., 87:1215-1221.
14. 2-macroglobulin with proteinases. Biochem. J., 133:709-724.
15. Baturay, N. Y., and Roque, H. 1991. In vitro reduction of peroxidation in UVC-irradiated cell cultures by concurrent exposure with Bowman-Birk protease inhibitor. Teratog. Carcinog., Mutagen, 11:195-202.
16. Bawadi, H. A., Antunes, T. M., Shih, F., and Losso, J. N. 2004. In vitro inhibition of the activation of pro-metalloproteinase-1 (pro-MMP-1) and prometalloproteinase-9 (pro-MMP-9) by rice and soybean Bowman-Birk inhibitors. J. Agric. Food Chem., 52:4730-4736.
17. Bernkop-Schnürch, A., Krauland, A., and Valenta, C. 1998. Development of drug delivery systems with protective effect towards Gl-proteinases. In: 2nd World Meeting on Pharmaceutics, Biopharmaceutics, Pharmaceutical Technology, pp. 989-990. APGI/APV Ed., Paris.
18. Billings, P. C., Habres, J. M., Liao, D. C., and Tuttle, S. W. 1991. A protease activity in human fibroblasts which is inhibited by the anticarcinogenic Bowman-Birk protease inhibitor. Cancer Res., 51:5539-5543.
19. Billings, P. C., St. Clair, W. H., Maki, P. A., and Kennedy, A. R. 1992. Distribution of the Bowman-Birk protease inhibitor in mice following oral administration. Cancer Lett., 62:191-197.
20. Birk, Y. (1961). Purification and some properties of a highly active inhibitor of trypsin and chymotrypsin from soybeans. Biochim. Biophys.Acta, 54:378-38.
21. Birk, Y. 1976. Trypsin and Chymotryspin inhibitors from soybeans. Methods Enzymol., XLV:700-707.
22. Birk, Y. 1985. The Bowman-Birk inhibitor. Int. J. Peptide Protein Res., 25:113-131.
23. Birk, Y. 1987. Proteinase Inhibitors. In: Hydrolytic Enzymes. pp. 257-305. Neuberger, A. and Brocklehurst, K. Eds., Elsevier Science Publishers, New York.
24. Birk, Y., Gertler, A., and Khalef, S. 1963. A pure trypsin inhibitor from soya beans. Biochem. J., 87:281-284.
25. Birk, Y., Smirnoff, P., and Ramachandran, J. 1986. Photoreactive, active derivatives of trypsin and chymotrypsin inhibitors from soybeans and chickpeas. Adv. Exp. Med. Biol., 199:469-81.
26. Bosland, M. C., McCormick, D. L., Melamed, J., Walden. P. D., Zeleniuch-Jacquotte. A., and Lumey, L. H. 2002. Chemoprevention strategies for prostate cancer. Eur J Cancer Prev., Suppl 2:S18-27.
27. Brandon, D. L., Bates, A. H., and Friedman, M. 1989. Monoclonal antibody-based enzyme immunoassay of the Bowman-Birk protease inhibitor of soybean. J. Agric. Food Chem., 37:1192-1196.
28. Brandon, D. L., Bates, A. H., and Friedman, M. 1991. ELISA analysis of soybean trypsin inhibitors in processed foods. Adv. Exp. Med. Biol. 289:321-337.
29. Brenner, B. M., Meyer, T. W., and Hostetter, T. H. 1982. Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease. N. Engl. J. Med., 307:652-659.
30. Brown, W. E., Takio, K., Titani, K., and Ryan, C. 1985. Wound-induced trypsin inhibitor in alfalfa leaves: identity as a member of the Bowman-Birk inhibitor family. Biochemistry, 24:2105-2108.
31. Bueno, N. R., Fritz, H., Auerswald, E. A., Mentele, R., Sampaio, M., Sampaio, C. A., and Oliva, M. L. 1999. Primary structure of Dioclea glabra trypsin inhibitor, DgTI, a Bowman-Birk inhibitor. Biochem. Biophys. Res. Commun., 26:838-843.
32. Caggana, M., and Kennedy, A. R. 1989. c-fos mRNA levels are reduced in the presence of antipain and Bowman-Birk inhibitor. Carcinogenesis. 10(11):2145-2148.
33. Campfield, L. A. 1997. Metabolic and hormonal controls of food intake: highlights of the last 25 years- 1972-1997. Appetite, 29:135-152.
34. Carlini, C. R., and Grossi-de-Sa, M. F. 2002. Plant toxic proteins with insecticidal properties. A review on their potentialities as bioinsecticides. Toxicon, 40(11):1515-1539.
35. Carmeliet, P. 2005. Angiogenesis in life, disease and medicine. Nature, 438:932-936.
36. Carmeliet, P., and Jain, R. K. 2000. Angiogenesis in cancer and other diseases. Nature, 407:249-257.
37. Ceci, L. R., Volpicella, M., Rahbé, Y., Gallerani, R., Beekwilder, J., and Jongsma, M. A. 2003. Selection by phage display of a variant mustard trypsin inhibitor toxic against aphids, Plant J., 33:557-566.
38. Chang, J. D., Li, J. H., Billings, P. C., and Kennedy, A. R. 1990. Effects of protease inhibitors on c-myc expression in normal and transformed C3H 10T1/2 cell lines. Mol Carcinog., 3:226-232.
39. Chang, T. K., Chen, J., and Lee, W. B. 2001. Differential inhibition and inactivation of human CYP1 enzymes by trans-resveratrol: evidence for mechanism-based inactivation of CYP1A2. J Pharmacol. Exp. Ther., 299:874-882.
40. Chen, Y. N., Huang, S. C., Lin-Shiau, S. Y., and Lin, J. K. 2005. Bowman-birk inhibitor abates proteasome function and suppresses the proliferation of MCF7 breast cancer cells through accumulation of MAP kinase phosphatase-1. Carcinogenesisg, 26:1296-1306.
41. Chen, P., Rose, J., Love, R., Wei, C. H., and Wang, B. C. 1992. Reactive sites of an anticarcinogenic Bowman-Birk proteinase inhibitor are similar to other trypsin inhibitors. J Biol Chem., 267(3):1990-4.
42. Creemers, L. B., Jansen, I. D. C., Docherty, A. J. P., Reynolds, J. J., Beersten, W., and Everts, V. 1998. Gelatinase A (MMP-2) and cysteine proteinase are essential for the degradation of collagen in soft connective tissue. Matrix Biol., 17:35-46.
43. De Freitas, S. M., Mello, L. V., da Silva, C. M., Vriend, G., Neshich, G., and Ventura, M. 1997. Analysis of the black-eyed pea trypsin and chymotrypsin inhibitor α- chymotrypsin complex. FEBS Lett., 409:121-127.
44. Deguchi, J. O., Aikawa, M., Tung, C. H., Aikawa, E., Kim, D. E., Ntziachristos, V., Weissleder, R., Libby, P. 2006. Inflammation in atherosclerosis: visualizing matrix metalloproteinase action in macrophages in vivo. Circulation, 114:55-62.
45. Demuth, H. U., Schierhorn, A., Bryan, P., Hofke, R., Kirschke, H., and Bromme, D. 1996. N-peptidyl, O-acyl hydroxamates: comparison of the selective inhibition of serine and cysteine proteinases. Biochim. Biophys. Acta, 1295:179-186.
46. Dirsch, V. M., and Vollmar, A. M. 2001. Ajoene, a natural product with non-steroidal anti-inflammatory drug (NSAID)-like properties? Biochem. Pharmacol., 61:587-593.
47. Dittmann, K. H, Gueven, N., Mayer, C., Ohneseit, P., Zell, R., Begg, A. C., and Rodemann, H. P. 1998. The presence of wild-type TP53 is necessary for the radioprotective effect of the Bowman-Birk proteinase inhibitor in normal fibroblasts. Radiat. Res., 150:648-655.
48. Dittmann, K. H., Güven, N., Mayer, C., Ohneseit, P., Zell, R., Begg, A. C., and Rodemann, H. P. 1998a. The presence of wild-type TP53 is necessary for the radioprotective effect of the Bowman-Birk proteinase inhibitor in normal fibroblasts. Radiat. Res., 150:648-655.
49. Dittmann, K., Dikomey, E., Mayer, C., and Rodemann, H. P. 2000. The Bowman-Birk protease inhibitor enhances clonogenic cell survival of ionizing radiation-treated nucleotide excision repair-competent cells but not of xeroderma pigmentosum cells. Int. J. Radiat. Biol., 76:223-229.
50. Dittmann, K., Knaus-Dittmann, D., Mayer, C., and Rodemann, H. P. 2001. Bowman-Birk proteinase inhibitor-mediated radioprotection against UV irradiation is TP53-dependent and associated with stimulation of nucleotide excision repair. Radiat. Ernviron. Biophys., 40:163-167.
51. Dittmann, K., Toulany, M., Classen, J., Heinrich, V., Milas, L., and Rodemann, H. P. 2005. Selective Radioprotection of Normal Tissues by Bowman-Birk Proteinase Inhibitor (BBI) in Mice. Strahlenther Onkol., 181(3):191-196s, 161.
52. Domagalski, J. M., Kollipara, K. P., Bates, A. H., Brandon, D. L., Friedman, M., and Hymowitz, T. 1992. Nulls for the major soybean Bowman-Birk protease inhibitor in the genus Glycine. Crop. Sci. 32:1502-1505.
53. Domoney, C., and Welham, T. 1998. Limited proteolysis of enzyme inhibitor proteins during seed dessication in Pisum. J. Plant Physol., 52:692-695.
54. Domoney, C., Welham, T., and Sidebottom, C. 1993. Purification and characterization of Pisum seed trypsin inhibitors. J. Exp Bot., 44:701-709.
55. Domoney, C., Welham, T., Sidebottom, C., and Firmin, J. L. 1995. Multiple isoforms of Pisum trypsin inhibitors result from modification of two primary gene products. FEBS Lett. 360:5-20.
56. Du, X., Beloussow, K., and Shen, W. C. 2001. Bowman-Birk protease inhibitor and its palmitic acid conjugate prevent 7,12-dimethylbenz[a] anthracene-induced transformation in cultured mouse mammary glands. Cancer Lett., 164:135-141.
57. Duggleby, H. J., Tolley, S. P., Hill, C. P., Dodson, E. J., Dodson, G., and Moody, P. C. E. 1995. Penicillin acylase has a single amino-acid catalytic center. Nature, 373:264-268.
58. Duncan, M. E., Richardson, J. P., Murray, G. I., Melvin, W. T., and Fothergill J. E. 1998. Human matrix metalloproteinase-9: activation by limited trypsin treatment and generation of monoclonal antibodies specific for the activated form. Eur. J. Biochemg., 15:37-43.
59. Ekrami, H., Kennedy, A. R., and Shen, W. C. 1995. Disposition of positively charged Bowman-Birk protease inhibitor conjugates in mice: influence of protein conjugate charge density and size on lung targeting. J. Pharm. Sci., 84:456-461.
60. Ekrami, H., Kennedy, A. R., Witschi, H., and Shen, W. C. 1993. Cationized Bowman-Birk protease inhibitor as a targeted cancer chemopreventive agent. J. Drug Target, 1:41-49.
61. Evans, S. M., Szuhaj, B. F., Van Winkle, T., Michel, K., and Kennedy, A. R. 1992. Protection against metastasis of radiation induced thymic lymphosarcoma and weight loss in C57B1/6NCr1BR mice by an autoclave resistant factor present in soybeans. Radiat. Res., 132:259-262.
62. Ferrasson E., Quillien L., and Gueguen J. 1995. Amino acid sequence of a Bowman-Birk proteinase inhibitor from pea seeds. J. Protein Chem., 14:467-475.
63. Flecker, P. 1987. Chemical synthesis, molecular cloning and expression of gene coding for Bowman-Birk-type proteinase inhibitor. FEBS Lett., 252:151-156.
64. Folkman, J. 1971. Tumor angiogenesis: therapeutic implications. N. Engl. J. Med. 285:1182-1186.
65. Folkman, J. 2006. Angiogenesis. Annu Rev Med. 57:1-18.
66. Fratali, V., and Steiner, R. F. 1969. Soybean Inhibitors. II. Preparative electrophoretic purification of soybean proteinase inhibitors on polyacrylamide gels.Anal. Biochem., 27:285-291.
67. 2 formation by activated human polymorphonuclear leukocytes. Carcinogenesis, 8:1207-1212.
68. Friedman, M., and Brandon, D. L. 2001. Nutritional and health benefits of soy proteins. J. Agric Food Chem., 49:1069-1086.
69. Funk, A., Weder, J. K., and Belitz, H. D. 1993. Primary structures of proteinase inhibitors from Phaseolus vulgaris var. nanus (cv. Borlotto). Z Lebensm Unters Forsch. 196(4) :343-50.
70. German, B., Schiffrin, E. J., Reniero, R., Mollet, B., Pfeifer, A., and Neeser, J-R. 1999. The development of functional foods: lessons from the gut. Trends Biotech. 17:492-499.
71. Getler, A., and Birk, Y. 1970. Isolation and characterization of porcine proelastase. Eur J Biochem., 12:170-176.
72. Gladysheva I. P., Popykina N. A., Zamolodchikova T. S., and Larionova N. I. 2002. Study on interaction between duodenase-protease with dual specificity and inhibitors of Bowman-Birk family. Prot. Peptide Lett., 9:139-144.
73. Gladysheva, I. P., Balabushevich, N. G., Moroz, N. A., and Larionova, N. I. 2000. Isolation and characterization of soybean Bowman-Birk inhibitor from different sources. Biochemistry (Mosc.), 65:198-203.
74. Gladysheva, I. P., Larionova, N. I., Gladyshev, D. P., Tikhonova, T. V., and Kazanskaia, N. F. 1994. [The classical Bowman-Birk soy inhibitor is an effective inhibitor of human granulocyte alpha-chymotrypsin and cathepsin G]. Biokhimiia, 59(4):513-8. Russian.
75. Gladysheva, I. P., Polekhina, O. V., Karmakova, T. A., Nemtsova, E. R., Yakubovskaya, R. I., Shen, W., Kennedy, A. R., and Larionova, N. I. 2001a. Potential of block copolymer- and immuno-conjugates for tumor-targeted delivery of Bowman-Birk soybean proteinase inhibitor. J. Control Release, 74:303-308.
76. Gladysheva, I. P., Polekhina, O. V., Karmakova, T. A., Nemtsova, E. R., Yakubovskaya, R. I., Shen, W.-C., Kennedy, A. R., and Larinova, N. I. 2001c. Potential of block copolymer- and immuno-conjugates for tumor-targeter delivery of Bowman-Birk soybean proteinase inhibitor. J. Controlled Release, 74:303-308.
77. Gladysheva, I. P., Zamolodchikova, T. S., Sokolova, E. A., and Larionova, N. I. 1999. Interaction between duodenase, a proteinase with dual specificity, and soybean inhibitors of Bowman-Birk and Kunitz type. Biochem. (Mosc.), 64:244-1249.
78. Gladysheva, I. P., Zamolodchikova, T. S., Sokolova, E. A., and Larionova, N. I. 1999. Interaction between duodenase, a proteinase with dual specificity, and soybean inhibitors of Bowman-Birk and Kunitz type. Biochem. (Mosc.), 64:1244-1249.
79. Godebole, S. A., Krishna, T. G., and Bhatia, C. R. 1994. Purification and characterization of proteinases inhibitors from pigeon pea (Cajanus Cajan (L) Millsp) seeds. J. Sci. Food Agric., 64:87-93.
80. Grass, C., and Herlyn, M. 2001. Role of Cadherins and matrixins in melanoma. Curr. Opin. Oncol., 13:117-123.
81. Guerrero, A., and Rosell, G. 2005. Biorational approaches for insect control by enzymatic inhibition. Curr. Med. Chem., 12(4):461-469.
82. Habres, J. M., and Billings, P. C. 1992. Intestinal epithelial cells contain a high molecular weight protease subject to inhibition by anticarcinogenic protease inhibitors. Cancer Lett., 63:135-142.
83. Hamilton-Miller, J. M. 2001. Anti-cariogenic properties of tea (Camellia sinensis). J. Med. Microbiol., 50:299-302.
84. Hammond R. W., Foard, D. E., and Larkins, B. A. 1984. Molecular cloning and analysis of a gene coding for the Bowman-Birk protease inhibitor in soybean. J. Biol. Chem., 259(15):9883-9890.
85. Handsley M. M., and Edwards D. R. 2005. Metalloproteinases and their inhibitors in tumor angiogenesis. Int. J. Cancer 115:849-860.
86. Haq, M., Shafii, A., Zervos, E. E., and Rosemurgy, A. S. 2000. Addition of matrix metalloproteinase inhibition to conventional cytotoxic therapy reduces tumor implantation and prolongs survival in a murine model of human, pancreatic cancer. Cancer Res., 15:3207-3211.
87. Harry, J. B., and Steiner, R. F. 1969. Characterization of the self-association of a soybean proteinase inhibitor by membrane osmometry. Biochem., 8:5060-5064.
88. Hatano, K. I., Kojima, M., Tanokura, M., and Takahashi, K. 1996. Solution structure of bromelain inhibitor from pineapple stem: structural similarity with Bowman-Birk trypsin/chymotrypsin inhibitor from soybeans. Biochem., 35:5379-5384.
89. Haynes, R., and Feeney, R. E. 1967. Fractionation and properties of trypsin and chymotrypsin inhibitors from lima beans. Fractionation. J. Biol. Chem., 242:5378-5385.
90. Heath, E. I., and Grochow, L. B. 2000. Clinical potential of matrix metalloprotease inhibitors in cancer therapy. Drugs 59:1043-105.
91. Hilder, V. A., Barker, R. F., Samour, R. A., Gatehouse, A. M. R., Gatehouse, J. A., and Boulter, D. 1989. Protein and cDNA sequences of Bowman-Birk protease inhibitors from the cowpea (Vigna unguiculata Walp.). Plant Mol. Biol., 13:701-710.
92. Honeycutt, L., Wang, J., Ekrami, H., and Shen, W. C. 1996. Comparison of pharmacokinetic parameters of a polypeptide, the Bowman-Birk protease inhibitor (BBI), and its palmitic acid conjugate. Pharm. Res., 13(9):1373- 1377.
93. Horisberger, M., and Tacchini-Voulanthen, T. M. 1983. Ultrastractural localization of Bowman-Birk inhibitor on thin sections of Glycine max (soybean) cv. Maple Arrow by the gold method. Histochem. 77:313-321.
94. Hrabec, E., Strek, M., Nowak, D., and Hrabec, Z. 2001. Elevated level of circulating matrix metalloproteinase-9 in patients with lung cancer. Respir. Med., 95:1-4.
95. Huang, M. T., Xie, J. G., Lin, C .B., Kizoulis. M., Seiberg, M., Shapiro, S., and Conney, A. H. 2004. Inhibitory effect of topical applications of nondenatured soymilk on the formation and growth of UVB-induced skin tumors. Oncol. Res., 14:387-397.
96. Hwang, D. L., Lin, K. T., Yang, W. K., and Foard, D. E. 1977. Purification, partial characterization, and immunological relationships of multiple low molecular weight protease inhibitors of soybean. Biochim. Biophys. Acta, 495:369-382.
97. Ip, C., Lisk, D. J., and Scimera, J. A. 1994. Potential of food modification in cancer prevention CancerRes., 54:1957s-1959s.
98. Jane-Salas, E., Chimenos-Kustner ,E., Lopez-Lopez, J., and Rosello-Llabres, X. 2005. Importance of diet in the prevention of oral cancer. Med. Oral., 8:260-268.
99. Jensen, B., Unger, K. K., Uebe, J., Gey, M., Kim, Y.-M., and Flecker, P. 1996. Proteolytic cleavage of soybean Bowman-Birk inhibitor monitored by means of high-performance capillary electrophoresis. Implications for the mechanism of proteinase inhibitors. J. Biochem. Biophys. Methods, 33:171-185.
100. Jia, M. C, Schwartz, M. A., and Sang, Q. A. 2000. Suppression of human microvascular endothelial cell invasion and morphogenesis with synthetic matrixin inhibitors. Targeting angiogenesis with MMP inhibitors. Adv. Exp. Med. Biol., 476:181-194.
101. Jibson, M. D., Birk, Y., and Bewley, T. A. 1981. Circular dichroism spectra of trypsin and chymotrypsin complexes with Bowman-Birk or chickpea trypsin inhibitor. Int. J. Peptide Prot. Res., 18:26-32.
102. Joudrier, P. E., Foard, D. E., Floener, L. A., and Larkins, B. A. 1987. Isolation and sequence of cDNA encoding the soybean protease inhibitors PI IV and C-II. Plant Mol. Biol., 10:35-42.
103. Jung, R., Martino-Catt, S., Towsend, J., and Beach, L. 1997. Expression of a sulfur-rich protein in soybean seeds causes an altered seed protein composition. In: Abstract of the Seventh International Seed Protein Symposium, Gatersleben, Germany..
104. Kakade, M. L., Simons, N. R., and Liener, I. E. 1970. The molecular weight of the Bowman-Birk soybean protease inhibitor. Biochem. Biophys. Acta, 200:168-169.
105. Kalume, D. E., Sousa, M. V., and Morhy, L. 1995. Purification, characterization, sequence determination, and mass spectrometric analysis of a trypsin inhibitor from seeds of the Brazilian tree Dipteryx alata (Leguminosae). J. Protein Chem., 14:685-693.
106. Kassell, B. 1970. Trypsin and chymotrypsin inhibitors from soybeans. Methods Enzymol., 19:853-862.
107. Kay, J., Valler, M. J., and Dunn, B. M. 1982. Naturally-occurring inhibitors of aspartic proteinases. In: Proteinase Inhibitors: Medical and Biological Aspects. pp. 201-210. Katunuma, N. et al. (Eds.).
108. Kelloff, G. J., Crowell, J. A., Steele, V. E., Lubet, R. A., Malone, W. A., Boone, C. W., Kopelovich, L., Hawk, E. T., Lieberman, R., Lawrence, J. A., Ali, I., Viner, J. L., and Sigman, C. C. 2000. Progress in cancer chemoprevention: development of diet-derived chemopreventive agents, J. Nutr., 130:467S-471S.
109. Kennedy A. R., and Wan X. S. 2002. Effects of the Bowman-Birk inhibitor on growth, invasion, and clonogenic survival of human prostate epithelial cells and prostate cancer cells. Prostate, 50:125-133.
110. Kennedy, A. R. 1993. Anticarcinogenic activity of protease inhibitors: An Overview. In: Protease Inhibitors as Chemopreventive Agents. pp. 9-64. Troll, W. and Kennedy, A.R. (Eds.), Plenum Press.
111. Kennedy, A. R. 1996. A reply to Liener. J. Nutr. 126:584-584. .
112. Kennedy, A. R. 1998. The Bowman-Birk inhibitor from soybeans as an anticarcinogenic agent. Am. J. Clin. Nutr., 68(Suppl):1406S-1412S.
113. Kennedy, A. R., and Szuhaj, B. 1984. Bowman-Birk inhibitor product for use as an anticarcinogenesis agent, US Patent. 5,338,547.
114. Kennedy, A. R., Kritchevsky, D., and Shen, W. C. 2003. Effects of spermine-conjugated Bowman-Birk inhibitor (spermine-BBI) on. carcinogenesis and cholesterol biosynthesis in mice. Pharm. Res., 20:1908-1910.
115. Kennedy, A. R., Radner, B. S., and Nagasawa, H. 1984. Protease inhibitors reduce the frequency of spontaneous chromosome abnormalities in cells from patients with, bloom syndrome. Proc. Natl. Acad. Sci. USA., 81:1827-1830.
116. Kerwin, S. M. 2004. Soy saponins and the anticancer effects of soybeans and soy-based foods. Curr Med Chem Anticancer Agents, 4:263-272.
117. Kim, H. Y., Yu, R., Kim, J. S., Kim, Y. K., and Sung, M. K. 2004. Antiproliferative crude soy saponin extract modulates the expression of IkappaB alpha, protein kinase C, and cyclooxygenase-2 in human colon cancer cells. Cancer Lett., 210:1-6.
118. Kimura, M., Kouzuma, Y., Abe, K., and Yamasaki, N. 1994. On a Bowman-Birk family proteinase inhibitor from Erythrina variegata, seeds. J. Biochem., 115:369-372.
119. Kiyohara, T., Yokota, K., Masaki, Y., Matsui, O., Iwasaki, T., Yoshikawa, M. 1981. The amino acid sequences of proteinase inhibitors I-A and I-A′ from adzuki beans. J. Biochem. (Tokyo), 90:721-728.
120. Koepke, J., Ermler, U., Warkentin, E., Wenzl, G., and Flecker, P. (2000). Crystal structure of cancer chemopreventive Bowman-Birk inhibitor in ternary complex with bovine trypsin at 2.3 Å resolution. Structural basis of Janus-faced serine protease inhibitor specificity. J. Mol. Biol., 298:477-491.
121. Konijn, A. M., Birk, Y., and Guggenheim, K. 1970. In vitro synthesis of pancreatic enzymes:effect of soybean trypsin inhibitor. Am. J. Physiol., 218:1113-1117.
122. Koroma, B. M., and de Juan Jr., E. 1994. Phosphotyrosine inhibition and control of vascular endothelial cell proliferation by genistein. Biochem. Pharmacol, 48:809-818.
123. Krahn, J., and Stevens, F. C. 1970. Lima bean trypsin inhibitor. Limited proteolysis by trypsin and chymotrypsin. Biochem., 9:2646-2650.
124. 1 arginine residues in two reactive sites. J. Biochem., 101:1361-1367.
125. Kushi, L. H., Cunningham, J. E., Hebert, J. R., Lerman, R. H., Bandera, E. V., and Teas, J. 2001. The macrobiotic diet in cancer. J. Nutr., 131:3056S-3064S.
126. Larionova N. I., Tiourina O. P., Kazanskaya N. F., Ponchel G., and Duchene D. (1999b). Biodegradable microspheres with protein proteinase inhibitors for the protein delivery. Proc. Int. Symp. Control Rel. Bioact. Mater., 26:851-852.
127. Larionova N. V., Malykh E. V., Villemson A. L., Krasota A. J, Duchene D., Ollivon M., Gernet M. V., Belousova R. V., Shen W. C., and Larionova N. I. 2003. Effect of membranotropic and mucoadhesive formulations of protein proteinase inhibitors on bovine herpes virus-1 reproduction. Int. J. Pharm., 256:191-198.
128. Larionova, N. I, Gladysheva, I. P., Tikhonova, T. V., and Kazanskaia, N. F. 1993. Inhibition of cathepsin G and human granulocyte by multiple forms of Bowman-Birk soybean inhibitor. Biochem., (Mosc), 58:1046-1052.
129. Larionova, N. I., Balabushevitch, N. G., and Zhatikov, P. A. 1998. Interaction of human, leukocyte elastase with, plasma fibronectin and its inhibition by soybean. Bowman-Birk protease inhibitor. Biochem. (Mosc) 63:1078-1082.
130. Larionova, N. I., Gladysheva, I. P., and Gladyshev, D. P. 1997. Human leukocyte elastase inhibition by Bowman-Birk soybean inhibitor. Discrimination of the inhibition mechanism. FEBS Lett., 404:245-248.
131. Larionova, N. I., Gladysheva, I. P., and Gladyshev, D. P. 1997. Human leukocyte elastase inhibition by Bowman-Birk soybean inhibitor. Discrimination of the inhibition mechanisms. FEBS Lett., 404(2-3):245-248.
132. Larionova, N. I., Gladysheva, I. P., Polekhina, O. V., Kurochkina, L. P., and Gorbatova, E. N. 1996. Synthesis and biodistribution of Bowman-Birk soybean, protease inhibitor conjugate with amphiphilic polyester. Appl. Biochem. Biotechnol., 61:139-148.
133. Larionova, N. I., Gladysheva, I. P., Polekhina, O. V., Kurochkina, L. P., and Gorbatova, E. N. 1996. Synthesis and biodistribution of Bowman-Birk soybean protease inhibitor conjugate with amphiphilic polyester. Appl. Biochem. Biotechnol., 61(1-2):139-48.
134. Larionova, N. I., Topchieva, I. N., Gladysheva, I. P., and Kennedy, A. R. 1994. The Bowman-Birk inhibitor-polyester conjugate: synthesis, inhibition of serine proteinases, and suppression of radiation transformation in vitro. Cancer J., 7:158-163.
135. Laskowski, M. D., and Kato, I. 1980. Protein inhibitors of proteinases. Ann. Rev. Biochem. 49:593-626.
136. Lee, S., Tomasetto, C., Paul, D., Keyomarsi, K., and Sager, R. 1992. Transcriptional downregulation of gap-junction proteins block junctional communication in human mammary tumor cell lines. J. Cell Biol., 118:1213-1221.
137. Li, N., Qu, L. J., Liu, Y., Li, Q., Gu, H., and Chen, Z. 1999. The refolding, purification, and activity analysis of a rice Bowman-Birk inhibitor expressed in Escherichia coli. Prot. Expr. Purif., 15:99-104.
138. Liener, I. E., and Hasdai, A. 1985. The effect of the long-term feeding of raw soyflour on the pancreas of the mouse and hamster. In Adv. Exp. Med. Biol., 199:189-197.
139. Liener, I. E., Goodale, R. L., Deshmukh, A., Satterberg, T. L. Ward, G., DiPietro, C. M., Bankey, P. E., Borner, J. W. (1988). Effect of a trypsin inhibitor from soybean (Bowman-Birk) on the secretory activity of the human pancreas. Gastroenterology, 94:419-42.
140. Lin, J. Y., and Hu, M. N. 1986. The Con A conjugate of Bowman-Birk soybean trypsin inhibitor as an anticancerogen. In: Lectins: Biology, Biochemistry, Clinical Biochemistry., pp. 409-416 Bog-Hansen, T. C., and van Driessche, E. Eds., Walter de Gruyter, Berlin, New York.
141. Lippman, S. M., and Matrisian, L. M. 2000. Protease inhibitors in oral carcinogenesis and chemoprevention. Clin. Cancer Res., 6:4599-4603.
142. Loewenstein, W. 1979. Junctional intercellular communication and the control of growth. Biochim. Biophys. Acta., 561:1-65.
143. Losso, J. N., Munene, C. N., and Bansode, R. R. 2004. Inhibition of metalloproteinase-1 activity by the soybean Bowman-Birk inhibitor. Biotechnol. Lett., 26:901-905.
144. Luckett, S., Garcia, R. S., Barker, J. J., Konarev, A. V., Shewry, P. R., Clarke, A. R., and Brady, R. L. (1999). High-resolution structure of a potent, cyclic proteinase inhibitor from sunflower seeds. J. Mol. Biol., 290:525-533.
145. Lupas, A., Zwickl, P., Wenzel, T., Seemuller, E. and Baumeister, W. 1995. Structure and function of the 20S proteasome and of its regulatory complexes. Cold Spring Harb Symp Quant. Biol., 60:515-524.
146. Maggo, S., Malhorta, S. P., Dhawan, K., and Singh, R. 1999. Purification and characterization of protease inhibitor from rice bean (Vigna umbellata T.) seeds. J. Plant Biochem. Biotechnol., 8:61-64.
147. Maki, P. A., and Kennedy, A. R. 1992. Humoral and cellular immune functions are not compromised by the anticarcinogenic Bowman-Birk inhibitor. Nutr. Cancer, 18:165-173.
148. Malkowicz, S. B., McKenna, W. G., Vaughn, D. J., Wan, X. S., Propert, K. J., Rockwell, K., Marks, S. H., Wein, A. J., and Kennedy, A. R. 2001. Effects of Bowman-Birk inhibitor concentrate (BBIC) in patients with benign prostatic hyperplasia. Prostate, 48:16-28.
149. Malykh, E. V., and Larionova, N. I. 2002. Study of antiproteinase activity of acylated derivatives of Bowman-Birk soybean proteinase inhibitor. Biochem., (Mosc), 67:1383-1387.
150. Malykh, E. V., Larionova, N. I., Villemson, A. L., and Shen, W.-C. 2001a. Conjugates of Bowman-Birk proteinase inhibitor with unsaturated fatty acids: preparation, characterization and the uptake by Caco-2 cells. Proceed. Int. Symp. Controll. Rel. Bioact. Mater., San Diego, USA, 28, pp. 123-124.
151. Malykh, E. V., Tiourina, O. P., and Larionova, N. I. 2001b. Acylation of Bowman-Birk soybean, proteinase inhibitor by unsaturated fatty acid derivatives. Biochem. (Mosc), 66:444-448.
152. Malykh, E. V., Villemson, A. L., Larionova, N. I., and Shen, W.-C. 2001c. Conjugates of soybean proteinase inhibitor (Bowman-Birk type) with fatty acids. Uptake by Caco-2 cells and transepithelial transport. Int. Conference on Pharmaceutics and Pharmaceutical Technology, VI Pharmatech., Brazil, pp. 294-295.
153. McBride, J. D., and Leatherbarrow, R. J. 2001. Synthetic peptide mimics of the Bowman-Birk inhibitor protein. Curr. Med. Chem., 8:909-917.
154. McGain, A. K., Chen, J. C. Wilson, K. A., and Tan-Wilson, A. L. 1989. Degradation of trypsin inhibitors during soybean germination. Phytochem., 28:1013-1017.
155. McMunnus, M. T., Laing, W. A., and Christeller, J. T. 1994. Wounding induces a series of closely related trypsin/chymotrypsin inhibitory peptides in leaves of tobacco. Phytochem., 37:921-926.
156. Meyskens, F. L. Jr. 2001. Development of difluoromethyl-ornithine and Bowman-Birk inhibitor as chemopreventive agents by assessment of relevant biomarker modulation: some lessons learned. IARC Sci. Publ., 154:49-55.
157. Millar, D. B. S., Willick, G. E., Steiner, R. F., and Frattali, V. 1969. The irreversible self-association of a soybean proteinase inhibitor. J. Biol. Chem., 244:281-840.
158. Morris, C. A., Morris, L. D., Kennedy A. R., and Sweeney H. L. 2005. Attenuation of skeletal muscle atrophy via protease inhibition. J. Appl. Physiol., 99:1719-1727.
159. Moy, L. Y., and Billings, P. C. 1994. A proteolytic activity in a human breast cancer cell line which is inhibited by the anticarcinogenic Bowman-Birk protease inhibitor. Cancer Lett., 85:205-210.
160. Munoz de Chavez, M., and Chavez, A. 1998. Diet that prevents cancer: recommendations from the American Institute for Cancer Research, Int. J. Cancer., 11:S85-S99.
161. Nagasue, A., Fukamachi, H., Ikenaga, H., and Funatsu, G. 1988. The amino acid of barley rootlet trypsin inhibitor. Agrice. Biol. Chem., 52:1505-1514.
162. National Institute of Dental and Craniofacial Research (NIDCR) Homepage. 2006. http://www.nidcr.nih.gov/HealthInformation/DiseasesAndConditions/ SpectrumSeries/OralCancerEnemy.htm. Accessed on online 14 August 2006.
163. Noel, A., Gilles, C., Bajou, K., Devy, L., Kebers, F., Lewalle, J. M., Maquoi, E., Manaut, C., Remade, A., and Foidart, J. M. (1997). Emerging role for proteases in cancer. Invasion Metastasis, 17:221-239.
164. Norioka, S., and Ikenaka, T. 1983. Amino acid sequences of trypsin-chymotrypsin inhibitors (A-I, A-II, B-I, and B-II) from peanut (Arachis hypogaea): a discussion on the molecular evolution of legume Bowman-Birk type inhibitors. J Biochem (Tokyo)., 94(2):589-99.
165. Norioka, S., Omichi, K., and Ikenaka, T. J. 1982. Purification and characterization of protease inhibitors from peanuts (Arachis hypogaea). J. Biochem., 991:1427-1434.
166. O'Donnell, C. D. 2001. Who would have thought...? Prepared Foods, 07 December.
167. Odani, S., and Ikenaka, T. 1973. Study on soybean trypsin inhibitors. VIII. Disulphide bridges in soybean Bowman-Birk proteinase inhibitor. J. Biochem., 74:697-715.
168. Odani, S., and Ikenaka, T. 1977. Studies on soybean trypsin inhibitors X. Isolation and partial characterization of four soybean double-headed proteinase inhibitors. J. Biochem., 82:1513-1522.
169. Odani, S., and Ikenaka, T. 1978. Studies on soybean trypsin, inhibitors. IV. Change of the inhibitory activity of Bowman-Birk inhibitor upon replacements of the alpha-chymotrypsin reactive site serine residue by other amino acids. J. Biochem., (Tokyo) 84:1-9.
170. Odani, S., Koide, T., and Ono, T. 1986. Wheat germ trypsin, inhibitors. Isolation and structural characterization of a single-headed and double-headed inhibitors of the Bowman-Birk type. J. Biochem., 100:975-983.
171. Otto, H.-H. and Schirmeister, T. 1997. Cysteine proteases and their inhibitors. Chem. Rev., 97:133-17.
172. Papastoitsis, G., and Wilson, K. A. 1991. Initiation of the degradation of the soybean Kunitz and Bowman-Birk trypsin inhibitors by a cysteine protease. Plant Physiol., 96:1086-1092.
173. Persiani, S., Yeung, A., Shen, W. C., and Kennedy, A. R. 1991. Polylysine conjugates of Bowman-Birk protease inhibitor as targeted anticarcinogenic agents. Carcinogenesis, 12:1149-1152.
174. Philipp, S., Kim, Y-M., Durr , I. Wenzl, G., Vogt, M., and Flecker, P. 1998. Mutational analysis of disulfide bonds in the trypsin-reactive subdomain of a Bowman-Birk type inhibitor of trypsin, and chymotrypsin. Cooperative versus autonomous refolding of subdomains. Eur. J. Biochem., 251:854-862.
175. Powers, J. C., Odake, S., Oleksynszn, J., Hori, H., Ueda, T., Boduszek, B., and Kim, C. M. (1993). Proteases- Structures, mechanism and inhibitors. In: Proteases, Protease Inhibitors and protease-derived peptides, pp. 3-18. Cheronis, J. C., and Repine, E.R., Eds. Birkhauser Verlag Basel.
176. Prakash, B, Murray, M. R., Sreerama, Y. N., Sarma, P. R., and Rao, D. R. 1994. Crystallization and preliminary X-ray diffraction studies on a trypsin/chymotrypsin double-headed inhibitor from horse gram. J. Mol. Biol., 235(1):364-366.
177. Prakash, B., Selvaraj, S., Murthy, M. R. N., Sreerama, Y. N., Rao, D. R., and Gowda, L. R. 1996. Analysis of the amino acid sequences of plant BowmanBirk Inhibitors. J. Mol. Evol., 42:560-569.
178. Pusztai, A. 1968. General, properties of a protease inhibitor from the seeds of kidney bean. Eur J Biochem., 5:252-259.
179. Quillien, L., Ferrasson, E., Molle, D., and Gueguen, J. 1997.Trypsin inhibitor polymorphism: multigene family expression and postradiational modification. J. Prot. Chem., 16:195-203.
180. Rackis, J. J. 1974. Biological and physiological factors in soybeans. J. Amer. Oil Chem. Soc., 51:161A-174A.
181. Rahbé, Y., Ferrasson, E., Rabesona, H., and Quillien, L. 2003. Toxicity to the pea aphid Acyrthosiphon pisum of anti-chymotrypsin isoforms and fragments of Bowman-Birk protease inhibitors from pea seeds, Insect Biochem. Mol. Biol., 33:299-306.
182. Rakwal, R., Kumar Agrawal, G., and Jwa, N. S. (2001).Characterization of a rice (Oryza sativa L.) Bowman-Birk proteinase inhibitor: tightly light, regulated induction in response to cut, jasmonic acid, ethylene and protein phosphatase 2A inhibitors. Gene, 263:189-198.
183. Rao, K. N., Hegde, S.S., Lewis, R. J., and Suresh, C. G. 1999. Crystallization and preliminary x-ray diffraction studies of a Bowman-Birk inhibitor from Vigna unguiculata seeds. Acta Crystallogr D. Biol. Crystallogr., 155:1920-1922.
184. Reseland, J. E., Holm, H., Jacobsen, M. B., Jenssen, T. G., Hanssen, L. E. 1996. Proteinase inhibitors induce selective stimulation of human trypsin, and chymotrypsin secretion, J. Nutr. 126:634-642.
185. Roebuck, B. D., Longnecker, D. S., Baumgartner, K. J., and Thron, C. D. 1985. Carcinogen-induced lesions in the rat pancreas: effects of varying levels of essential fatty acid. Cancer Res., 45:5252-5256.
186. Rogers, S. G. 1998. Biotechnology and the soybean. Am. J. Clin. Nutr. 68(6 Suppl):1330S-1332S.
187. Ryan, C. A. 1990. Protease inhibitors in plants: Genes for improving defenses against insects and pathogens. Ann Rev Phytopathol., 28:425-449.
188. Ryan, M. E., Usman, A., Ramamurthy, N. S., Golub, L. M., Greenwald, R. A. 2001. Excessive Matrix Metalloproteinase activity in diabetes inhibition by tetracycline analogues with zinc reactivity. Curr. Med. Chem. 8:305-316.
189. Ryle, A. P. 1970.The porcine pepsins and pepsinogens. Methods Enzymol., 19:316.
190. Sakai, E., Applebaum, S. W., and Birk, Y. 1989. Purification and characterization of trypsins from, the digestive tract of Locusta migratoria. Int. J. Pept. Prot. Res, 34:498-505.
191. Sawey, M. J. 2001. The role of nutrition in preventing and treating breast and prostate cancer. J. Nutr., 131:167S-169S.
192. Seemuller, U., Eulitz, M., Fritz, H., and Strobl, A. 1980. Structure of the elastase-cathepsin G inhibitor of the leech Hirudo medicinalis. Hoppe Seylers Z. Physiol. Chem., 361:1841-1846.
193. Seidl, D. S., and Liener, I. E. 1971. Guanidination of the Bowman-Birk soybean inhibitor: evidence for the tryptic hydrolysis of peptide bonds involving homoarginine. Biochem. Biophys. Res. Commun., 42:1101-1107.
194. Sessa, D. J., Baker, E. C., and Friedrich, J. P. 1988. Inactivation of trypsin inhibitors in whole and cracked soybeans with sodium metabisulfite. Lebensm.-Wiss. U-Technol., 21:163-168.
195. Song, H. K., Kim, Y. S., Yang, J. K., Moon, J., Lee, J. Y., and Sun, S. W. 1999. Crystal structure of a 16 kDa double-headed Bowman-Birk trypsin inhibitor from barley seeds at 1.9 A resolution. J. Mol. Biol., 293:1133-1144.
196. Soule, H. D., Vazquez, J., Long, A., Albert, S., and Brennan, M. 1973. A human cell from, a pleural effusion derived from a breast carcinoma. J. Natl. Cancer Inst., 51:1409-1413.
197. Sreerama, Y. N., and Gowda, L. R. 1997. Antigenic determinants and reactive sites of a trypsin/chymotrypsin double-headed inhibitor from horse gram (Dolichos biflorus). Biochim. Biophys. Acta, 1343:235-242.
198. St Clair, W. H., Billings, P. C., and Kennedy, A. R. 1990. The effects of the Bowman-Birk protease inhibitor on c-myc expression and cell proliferation in the unirradiated and irradiated mouse colon. Cancer Lett., 52:145-152.
199. St. Clair, W. H., and St Clair, D. K. 1991. Effect of the Bowman-Birk protease inhibitor on the expression of oncogenes in the irradiated rat colon. Cancer Res., 51:4539-4543.
200. Stahlhut, R. W., and Hymowitz, T. 1983. Variation in the low molecular weight. proteinase inhibitors of soybeans. Crop. Sci. 23:766-76.
201. Stetler-Stevenson, W. G. 1999. Matrix metalloproteinases in angiogenesis: a moving target, for therapeutic intervention.J. Clin. Invest., 103:1237-1241.
202. Stewart, B. W., and Coates, A. S. 2005. Cancer prevention: a global, perspective, J. Clin. Oncol., 23:392-403.
203. Stockley, R. A. 2001. Proteases and antiproteases. Novartis Found. Symp., 234:189-99.
204. Stroud, R. M., Krieger, M., Koeppe, R. E., Kossiakoff, A. A., and Chambers, J. L. 1975. Structure-function relationships in the serine proteases. In Proteases and Biological Control. pp.13-32 Reich., E. Rifkin, D.B. and Shaw, E. Eds. Cold Spring Harbor Laboratory.
205. Sun, X. Y., Donald, S. P., and Phang, J. M. 2001. Testosterone and prostate specific antigen stimulate generation of reactive oxygen species in prostate cancer cells. Carcinogenesis, 22:1775-1780.
206. Tan-Wilson, A., Cosgriff, S. E., Duggan, M. C., Obach, R. S., and Wilson, K. A. 1985. Bowman-Birk proteinase isoinhibitor complements of soybean strains. J. Agric. Food Chem., 33:389-393.
207. Tan-Wilson, A., Rightmire, B. R., and Wilson, K. A. 1982. Different rates of metabolism of soybean proteinase inhibitors during germination. Plant Physiol., 70:493-497.
208. Tani, K., Ogushi, F., Kido, H., Kawano, T., Kunori, Y., Kamimura, T., Cui, P., and Sone, S. 2000. Chymase is a potent chemoattractant for human monocytes and neutrophils. J. Leukoc. Biol., 67:585-589.
209. Tashiro, M., and Maki, Z. 1979. Purification and characterization of a trypsin inhibitor from rice bran. J. Nutr. Sci. Vitaminol (Tokyo), 25(3):255-64.
210. Tashiro, M., Hashino, K., Shiozaki, M., Ibuki, F., and Maki, Z. 1987. The complete amino acid sequence of rice bran trypsin inhibitor. J. Biochem., 102:297-306.
211. Tikhonova T. V., Gladysheva I. P., Kazanskaia N. F., and Larionova, N. I. 1994. Hydrolysis of elastin by human leukocyte elastase and cathepsin G: Inhibition by Bowman-Birk-type soybean inhibitor. Biochem., (Mosc) 59:1295-1299.
212. Tikhonova, T. V., Gladysheva, I. P., and Larionova, N. I. 1995. Retardation by the soybean Bowman-Birk inhibitor of elastin hydrolysis catalyzed by leukocyte proteinases. FEBS Lett., 362:225-228.
213. Tolcher, A. W., Kennedy, A. R., Padley, R. J., Majeed, N., Pollak, M., and Kantoff, P. W 2001. Other novel agents: Rationale and current status as chemopreventive agents. Urology, 57(Suppl 1):86-89.
214. Troll, W. 1993. Prevention of cancer by vitamin B3 (nicotamide and nicotinic acid): A protease inhibitor available in pure form. In: Protease Inhibitors as Cancer Chemopreventive Agents, pp. 177-189. Troll, W. and Kennedy, A.R. Eds. Plenum Press, New York.
215. Turner, R., Liener, I. E., and Lovrien, R. E. 1975. Equilibria of Bowman-Birk inhibitor association, with, trypsin and α-chymotrypsin. Biochem., 14:275-282.
216. US Pat-ent 5,217,717. 1993. Kennedy; A. R. (Wynnewood, PA) and Szuhaj; B. R (Fort Wayne, IN). Method of making soybean. Bowman-Birk inhibitor concentrate and use of same as a human, cancer preventative and therapy.
217. US Patent. 5,338,547.(August 16, 1994). Kennedy; Ann R. (Wynnewood, PA), Szuhaj; Bernard R (Fort Wayne, IN). Bowman-Birk inhibitor product for use as an anticarcinogenesis agent.
218. US Patents 6,887, 498. (May 3, 2005). Konwinski; Arthur H. (Fort Wayne, IN), Szuhaj; Bernard R (Fort Wayne, IN). Method of making Bowman-Birk inhibitor product.
219. van den Hout, R., Pouw, M., Gruppen, H., and van't Riet, K. 1998. Inactivation kinetics study of the Kunitz soybean trypsin inhibitor and the Bowman-Birk Inhibitor. J. Agric. Food Chem., 46:281-285.
220. Von der Helm, K., Korant, B. D., and Cheronis, J. C. 2000. In: Proteases as targets for therapy. Von der Helm, K., Korant, B.D., and Cheronis, J.C Eds.,SpringerVerlag. Berlin, Heidelberg, New York.
221. Von Hofe, E., Brent, R., and Kennedy, A. R. 1990. Inhibition of X-ray induced exencephaly by protease inhibitors. Radiat. Res, 123:108-111.
222. Voss, R. H., Ermler, U., Essen, L. O., Wenzl, G., Kim, Y. M., and Flecker, P. 1996. Crystal structure of the bifunctional soybean Bowman-Birk inhibitor at 0.28-nm resolution. Structural, peculiarities in a folded protein, conformation. Eur J Biochem., 242(1):122-31.
223. Wan, X. S., Lu, L. J. W.; Anderson, K. E., Ware, J. H.; and Kennedy, A. R. 2000. Urinary excretion of Bowman-Birk inhibitor in human after soy consump tion as determined by a monoclonal antibody-based immunoassay. Cancer Epidemiol. Biomarkers Prev., 9:741-747.
224. Wan, X. S., Serota, D. G., Ware, J. H., Crowell, J. A., and Kennedy, A. R. 2002. Detection of Bowman-Birk inhibitor and anti-Bowman-Birk inhibitor antibodies in sera of humans and animals treated with Bowman-Birk inhibitor concentrate. Nutr. Cancer, 3:167-173.
225. Ware, J. H., Wan, X. S., Newberne, P., and Kennedy, A. R. 1999. Bowman-Birk inhibitor concentrate reduces colon inflammation in mice with dextran sulfate sodium-induced ulcerative colitis. Dig. Dis. Sci. 44:986-990.
226. Ware, J. H., Wan, X. S., Rubin, H., Schechter, N. M., and Kennedy, A. R. 1997. Soybean Bowman-Birk protease inhibitor is a highly effective inhibitor of human mast cell chymase. Arch. Biochem. Biophys., 344:133-138.
227. Wattenberg, L. W. 1992. Inhibition of carcinogenesis by minor dietary constituents. Cancer Res., 52:2085s-2091s.
228. Weder, J. K. 1986. Inhibition of human proteinases by grain legumes. Adv. Exp. Med. Biol., 199:239-279.
229. Weder, J. K., and Haussner, K. 1991. Inhibitors of human and bovine trypsin and chymotrypsin in fenugreek (Trigonella foenum-graecum L.) seeds. Isolation and characterization. ZLebensm Unters Forsch., 192:535-540.
230. Weder, J. K., and Haussner, K. 1991. Inhibitors of human and bovine trypsin and chymotrypsin. in fenugreek (Trigoneilafoenum-graecum L.) seeds. Reaction with the human, and bovine proteinases. Z Lebensm Unters Forsch., 193:321-325.
231. Weder, J. K., and Haussner, K. 1991. Inhibitors of human and bovine trypsin and chymotrypsin in fenugreek (Trigoneilafoenum-graecum L.) seeds. Reactive sites and C-terminal sequences. Z Lebensm Unters Forsch., 193:242-246.
232. Werner, M. H., and Wemmer, D. E. 1991. Identification of a protein-binding surface by differential amide hydrogen-exchange measurements. Application to Bowman-Birk serine-protease inhibitor. Biochem., 30:3356-3364.
233. Wilgenbus, K. K., Kirkpatrick, C. J., Knuechel, R., Willecke, K., and Traub, O. 1992. Expression of Cx26, Cx32 and Cx43 gap junction proteins in normal and neoplastic human tissues. Int. J. Cancer, 51:522-529.
234. Willett, W. C. 2000. Diet and cancer: Oncologist, 5(5):393-404.
235. Willett, W. C. 2001. Diet and cancer: one view at the start of the millennium. Cancer Epidemiol. Biomarkers Prev., 10:3-8.
236. Woessner, J. E Jr. 2002. MMPs and TIMPs-a historical perspective. Mol. Biotechnol., 22:33-49.
237. Wu, C., and Whitaker, J. R. (1991). Homology among trypsin/ chymotrypsin inhibitors from red kidney bean, brazilian pink bean, lima bean, and soybean. J. Agric. Food Chem., 39:1583-1589.
238. Wu, Y. V., and Sessa, D. J. (1994). Conformation of Bowman-Birk inhibitor. J. Agric. Food Chem., 42:2136-2138.
239. Yavelow, J., Collins, M., Birk, Y., Troll, W., and Kennedy, A. R. 1985. Nanomolar concentrations of Bowman-Birk soybean protease inhibitor suppress X-ray induced transformation in vitro. Proc. Natl. Acad. Sci. USA. 82:5395-5399.
240. Yavelow, J., Finlay, T. H., Kennedy, A. R., and Troll, W A. 1983. Bowman-Birk soybean protease inhibitor as an anticarcinogen. Cancer Res., 43:2454-2459.
241. Ye, X. Y., Ng, T. B, and Rao, P. F. 2001. A Bowman-Birk-type trypsin-chymotrypsin inhibitor from broad beans. Biochem. Biophys. Res. Commun., 289:91-96.
242. Yeboah, N. A., Arahira, M., Udaka, K., and Fukuzawa, C. 1996. A rapid purification method for soybean Bowman-Birk protease inhibitor using hydrophobic interaction chromatography. Prot. Expr. Purif, 7:309-314.
243. Yen, J. T., Jensen, A. H., and Simon, J. 1977. Effect of dietary raw soybean and soybean trypsin inhibitor on trypsin and chymotrypsin activities in the pancreas and in small intestinal juice of growing swine. J. Nutr., 107:156-165.
244. Zablotna, E., Kazmierczak, K., Jaskiewicz A., Stawikowski, M., Kupryszewski, G., and Rolka, K. 2002. Chemical synthesis and kinetic study of thesmallest naturally occurring trypsin inhibitor SFTI-I isolated from sunflower seeds and its analogues. Biochem Biophys Res Commun. 292:855-859.
245. Zamolodchikova, T. S., Vorotyntseva, T. I., Najimov, T. V., and Grishina, G. A. 1995. Duodenase, a new serine protease of unusual specificity from bovine duodenal mucosa. Primary structure of the enzyme. Eur. J. Biochem., 227:873-879.
246. Zhu, G., Huang, Q., Zhu, Y., Li, Y., Chi, C., and Tang, Y. 2001. X-Ray study on an artificial mung bean inhibitor complex with bovine beta-trypsin in neat cyclohexane. Biochim. Biophys. Acta, 1546:98-106.
247. Zimacheva, A. V. and Mosolov, V. V. 1995. Cysteine proteinase inhibitors from soy seeds. Biokhimiia, 60:118-123.